Key Points Eli Lilly's dominance in its core area and diversification efforts should allow it to perform well and regularly increase its dividend. Despite some headwinds, Merck's long-term prospects look bright, and its dividend program appears safe. 10 stocks we like better than Eli Lilly › Several investing trends are sweeping through Wall Street right now, including artificial intelligence (AI), robotaxis, and others. Investors shouldn't miss the opportunity to capitalize on these fast-growing markets, but it's also important not to forget tried-and-true methods for earning above-average long-term returns. One of them is to invest in excellent dividend-paying companies.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.